Today: 9 June 2026
Browse Category

NYSE:MMM 11 October 2025 - 19 January 2026

Dow Jones futures drop on Trump tariff threat as Wall Street sets up for Netflix, PCE week

Dow Jones futures drop on Trump tariff threat as Wall Street sets up for Netflix, PCE week

The Dow closed down 0.2% at 49,359.33 on Friday ahead of the MLK Day market holiday. Dow futures fell 0.7% after President Trump threatened a 10% tariff on imports from eight European nations tied to Greenland, with the rate set to rise to 25% in June if talks fail. European leaders condemned the move and gold hit new highs as investors sought safety. Traders await key earnings and Thursday’s PCE inflation data.
Industrial stocks led last week: XLI ends at $166.90 as tariffs, 3M and GE earnings loom

Industrial stocks led last week: XLI ends at $166.90 as tariffs, 3M and GE earnings loom

The Industrial Select Sector SPDR Fund (XLI) closed Friday up 0.68% at $166.90, capping a week where industrials gained 3.03%. Industrial-focused equity funds drew $2.61 billion in inflows for the week ending Jan. 14. The Dow slipped 0.17% and the S&P 500 fell 0.06% Friday, with all major indexes finishing the week lower. President Trump announced a 10% tariff on select European imports starting Feb. 1.
3M stock today: MMM closes 2025 lower as markets shut; what investors are watching next

3M stock today: MMM closes 2025 lower as markets shut; what investors are watching next

3M shares fell 0.7% to $160.10 in the final 2025 trading session, ending a year up about 25%. The S&P 500 dropped 0.74% on the day. Investors await 3M’s next earnings report, tentatively set for Jan. 27, and updates on profit outlook, legal liabilities, and cash flow after a $10.3 billion PFAS settlement. U.S. markets were closed Thursday for New Year’s Day.
Industrials Stocks Outlook: Defense, Transport, and Capex Themes Head Into the Final Week of 2025

Industrials Stocks Outlook: Defense, Transport, and Capex Themes Head Into the Final Week of 2025

U.S. industrials stocks held gains in thin post-holiday trading, with the sector seen as a year-end leader despite light volume. Defense shares drew attention after China imposed new sanctions on U.S. firms tied to Taiwan arms sales. The broader market closed slightly lower Friday, tracking the seasonal “Santa Claus rally” period. Investors are watching defense spending, transport demand, and business investment as 2026 approaches.
3M Stock (MMM) News, Forecasts and Analyst Outlook for Dec. 20, 2025: Margin Gains Meet PFAS Deadlines

3M Stock (MMM) News, Forecasts and Analyst Outlook for Dec. 20, 2025: Margin Gains Meet PFAS Deadlines

3M shares closed at $161.96 on Dec. 20, 2025, putting the company’s market cap in the mid-$80 billion range, down from early December highs but well above spring levels. The stock sits about 7% below its 52-week peak. 3M raised its annual profit forecast twice in 2025, citing higher-margin products and cost controls. The company also reduced its estimate of 2025 tariff-related impacts as trade tensions eased.
3M (MMM) Stock: What to Know Before the U.S. Market Opens on Monday, Dec. 15, 2025

3M (MMM) Stock: What to Know Before the U.S. Market Opens on Monday, Dec. 15, 2025

3M shares traded near $168.90 ahead of Monday’s open after Deutsche Bank downgraded the stock to “Hold” and cut its price target to $178, citing valuation concerns following a strong rally. Analyst targets now cluster just above current levels, with FactSet’s average at $179. The company’s Q3 report showed 3.2% organic sales growth and adjusted EPS of $2.19, beating expectations.
15 December 2025
3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M shares closed at $171.56 on December 2, 2025, near a four-year high and up about 31% over the past year. Technical models show short-term bullish momentum, but long-term forecasts from CoinCodex and StockScan project a possible decline to around $133 by 2026–2030. The company’s market cap stands at $91 billion with a dividend yield of 1.7%. Investors remain split over legal risks and recent gains.
3M (MMM) Stock Near 52‑Week High: Turnaround, Legal Overhangs and Dividend Reset – What Matters on November 29, 2025

3M (MMM) Stock Near 52‑Week High: Turnaround, Legal Overhangs and Dividend Reset – What Matters on November 29, 2025

3M closed at $172.05 on November 28, 2025, just below its 52-week high, with shares up nearly 29% over the past year. Q3 results beat expectations, with organic sales up 3.2% and full-year EPS guidance raised to $7.95–$8.05. The company reset its dividend to $0.73 per quarter after the Solventum spin-off. Market capitalization stands near $92 billion.
30 November 2025
3M (MMM) Stock Today, November 24, 2025: Fresh Valuation Calls, New PFAS Ruling and What’s Next for Investors

3M (MMM) Stock Today, November 24, 2025: Fresh Valuation Calls, New PFAS Ruling and What’s Next for Investors

3M shares closed at $168.09 on Friday, up 32% over the past year and trading just below their 52-week high. Q3 results showed organic sales growth above 3% and adjusted EPS up 10%, with full-year EPS guidance raised. Handelsbanken Fonder AB increased its stake by 17%. PFAS liabilities persist, though 3M won a procedural victory in Maine and maintains its dividend at $0.73 per share.
24 November 2025
3M Stock Set to Soar! PFAS Settlement and Dividends Spark Rally (Oct 2025)

3M Stock Soars on Earnings Beat & Turnaround Progress – What Investors Need to Know

3M shares closed at $154.78 on Oct. 20, up 17.5% year-on-year, after Q3 earnings beat estimates and the company raised full-year guidance. The firm reported adjusted EPS of $2.19 on $6.3 billion revenue and now expects 2025 EPS of $7.95–$8.05. Legal liabilities from PFAS and earplug lawsuits persist, with a key PFAS trial set for late October. Analyst sentiment has improved, with price targets rising to as high as $185.
Is 3M Stock Poised for a Comeback? Key Facts & Analysts’ Take (Oct 2025)

Is 3M Stock Poised for a Comeback? Key Facts & Analysts’ Take (Oct 2025)

3M closed at $148.75 on Oct. 11, down about 6% over the past week and 4% below late September levels. The company reported Q2 adjusted EPS of $2.16, up 12% year-over-year, and raised full-year guidance. 3M faces ongoing PFAS and earplug litigation, with $2.2 billion in related Q2 payments. Wall Street’s average 12-month price target is $165.60, with most analysts rating the stock a “Moderate Buy.”
12 October 2025

Stock Market Today

  • NSE Allocates 10% of Annual CSR Fund to Social Stock Exchange
    June 9, 2026, 10:16 AM EDT. The National Stock Exchange (NSE) will deploy 10% of its annual Corporate Social Responsibility (CSR) corpus through the Social Stock Exchange, signaling trust in this market-based platform designed to connect social enterprises with investors. This move aims to enhance transparency and impact investing by leveraging the exchange's resources to support social causes.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Go toTop